This year’s plenary topic, The Status of Inherited Muscle Diseases in 2022, has been chosen by AANEM President Holli Horak, MD, to highlight the dramatic changes in how we assess and treat persons with muscle diseases.
"As physiatrists, neurologists, and health care professionals we all want to perform the most accurate evaluations and provide the best, latest treatment options to our patients. Meeting attendees will learn about assessment techniques such as genetic testing, and hear about new treatments such as exon skipping for Duchenne’s muscular dystrophy" said Dr. Horak. "Whether someone is just starting their career or they are well established, I feel that this year’s plenary will help all of us."
2022 Plenary Speakers:
From Histological Harpoons to Genetic Scissors: A Journey Through the Muscular Dystrophies
Olney Lecture
Pushpa Narayanaswami, MD
Associate Professor of Neurology, Harvard Medical School
Vice-Chair (Clinical Operations), Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA
Novel Therapeutic Approaches to LGMD
Lambert Lecture
Kevin M. Flanigan, MD
Director, Center for Gene Therapy, Abigail Wexner Research Institute
Robert F. & Edgar T. Wolfe Foundation Endowed Chair in NM Research
Ohio State University Nationwide Children's Hospital, Columbus, OH
Diagnosis and Management of LGMD
Teerin Liewluck, MD
Associate Professor, Muscle Pathology Laboratory and Division of NM
Medicine, Department of Neurology, Mayo Clinic, Rochester, MN
The Current Approach to Management of Inherited Muscle Disease
Aloysia L. Schwabe, MD
Division Chief of Pediatric PM&R, Baylor College of Medicine and Texas Children’s Hospital
Associate Professor, Baylor College of Medicine, Departments of PM&R and Pediatrics
Co-Director, Texas Children’s Hospital Motion Lab
Advisory Board Member, Texas A&M Department of Biomedical Engineering
Texas Children's Hospital, Houston, TX
New Treatments for Duchenne Muscular Dystrophy
Reiner Lecture
Emma Ciafaloni, MD
Robert C. and Rosalyne H. Griggs Professor in Experimental Therapeutics of Neurologic Disease
Professor of Neurology, Pediatrics and Obstetrics and Gynecology, University of Rochester, Rochester, NY
Surinderjit Singh Young Lecture
Visit the ANF website for more details on this award.
Molly M. Fuentes, MD, MS
Assistant Professor, University of Washington, Seattle Children's Hospital, Seattle, WA